CJC Peptide Therapy Studies
CJC peptides (CJC‑1293 and CJC‑1295) are GHRH analogs designed to enhance GH secretion with extended half‑life.
02
Apr
Blog
02
Apr
Tesamorelin Growth Hormone Research
Tesamorelin is a synthetic GHRH analog approved for reducing visceral adipose tissue in HIV‑associated lipodystro...
02
Apr
Tirzepatide Peptide Innovation
Tirzepatide is a dual GIP/GLP‑1 receptor agonist that has demonstrated superior weight loss outcomes compared to ...
02
Apr
Semaglutide Clinical Applications
Semaglutide is a GLP‑1 receptor agonist widely recognized for its dual role in type 2 diabetes management and wei...
02
Apr
Retatrutide Weight Loss Research
Retatrutide is an investigational triple‑agonist peptide that simultaneously activates GLP‑1, GIP, and glucagon r...